Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

3.16
-0.0300-0.94%
Post-market: 3.220.0632+2.00%19:30 EDT
Volume:716.03K
Turnover:2.32M
Market Cap:228.19M
PE:-1.93
High:3.34
Open:3.21
Low:3.14
Close:3.19
52wk High:3.60
52wk Low:1.21
Shares:72.21M
Float Shares:37.05M
Volume Ratio:1.45
T/O Rate:1.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:3.98
PE(LYR):-1.58

Loading ...

Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025

Major Issues Report

Form 8-K - Current report